tirzepatide through lilly Shows Superiority in SURMOUNT-3 and 4 Lilly, Novo Fight Weight Loss

In addition to a long COVID diagnosis, participants must be at least 18 years of age with internet access, a fatigue severity scale score of at least 36 and be willing to follow study protocols

Tirzepatide was the first Health Canada-authorized peptide drug to activate both GIP and GLP-1 receptors with one molecule

It generally improves over time

At 15 mg weekly (the maximum FDA-approved dose), a 10 mg/mL vial requires 150 units, or 1.5 mL, per injection

GLP-1 agonists like semaglutide lower blood sugar by mimicking the bodys natural hormone glucagon-like peptide-1 (GLP-1), which triggers insulin secretion and blocks glucagon, a hormone that raises blood sugar levels

Contact us today for more information or schedule an appointment online